Sales by Industry:

• Health and medical apparel: 100%

TOP 3 Markets:

1. USA: approximately 85%
2. Canada: approximately 7%
3. United Kingdom: approximately 5%

FIGS, Inc. specializes in the manufacturing and sale of medical professional apparel, particularly for healthcare professionals. The majority of sales are generated in the USA, attributed to the strong market presence and direct distribution channel in the domestic market.

Canada and the United Kingdom are also important markets where FIGS has successfully established its products. The focus on high-quality, functional, and fashionable workwear has helped the company position itself in these markets.

Production Sites: Mexico, Vietnam, China

FIGS, Inc. primarily produces its medical professional clothing in Mexico, Vietnam, and China. These sites were chosen for cost-efficient production and proximity to key markets. Diversifying production sites helps the company minimize risks in the supply chain and respond flexibly to demand fluctuations.

Revenue Growth: Estimated 8-10% annually (2026 forecast)

Market Expansion: Targeted international expansion

Product Diversification: Introduction of new product lines

FIGS, Inc. is pursuing a growth strategy based on several pillars. Firstly, the company plans to expand its international presence to tap into new markets and reduce its dependence on the US market. This includes both entering new countries and strengthening existing international markets.

Secondly, FIGS is focusing on product diversification. The company is continuously expanding its product portfolio to go beyond traditional medical apparel products. This could involve introducing new clothing lines or accessories tailored to the needs of medical professionals.

In addition, FIGS is investing in technology and e-commerce to enhance the customer experience and increase supply chain efficiency. By leveraging data analysis and digital marketing, the company aims to expand its customer base and strengthen brand loyalty.

Main raw materials: Polyester, cotton, elastane

Countries of origin: China, Vietnam, Bangladesh

FIGS, Inc. sources the main raw materials for its medical clothing, such as polyester, cotton, and elastane, mainly from Asian countries. China is a significant supplier of polyester and elastane, while cotton is often imported from Vietnam and Bangladesh. These countries are known for their textile production and offer cost-effective materials suitable for the production of medical workwear.

The selection of supplier countries is based on the availability of raw materials, production capacities, and cost structures that enable FIGS to remain competitive.

Market share in the premium segment: 25% (estimated, 2026)
Customer satisfaction: 4.5 out of 5 stars (2025, customer surveys)
Innovation rate: Introduction of 3 new product lines per year (on average, 2023-2025)

FIGS, Inc. has established a strong competitive advantage in the field of medical professional apparel, especially in the premium segment. The company has differentiated itself from the competition through high-quality materials and stylish design, reflected in an estimated market share of 25% in this segment.

The high customer satisfaction, demonstrated by average ratings of 4.5 out of 5 stars, underscores the loyalty of the customer base. Additionally, FIGS continuously invests in innovation by regularly introducing new product lines, further enhancing brand attractiveness and market position.

Another advantage lies in direct customer engagement through digital channels, enabling FIGS to quickly respond to market trends and increase customer loyalty. The combination of product quality, innovation, and customer focus gives the company a sustainable competitive advantage.

Institutional Investor Share: Approximately 60% (estimated for 2026)
Insider Buys/Sells: No significant transactions in the last quarter (estimated for 2026)

The institutional investor share at FIGS, Inc. is estimated to be around 60%, indicating a strong trust from institutional investors in the company. These investors typically include pension funds, investment funds, and other large financial institutions that have a long-term perspective.

There were no significant insider buys or sells in the last quarter, suggesting that the management and other insiders are currently not making significant changes to their holdings. This could be seen as a sign of stability and confidence in the current company strategy.

Market share of FIGS, Inc.: Estimated 12% (2026)

Main competitors and their market shares:

1. Medline Industries: 20%
2. Cardinal Health: 18%
3. 3M Company (Healthcare Division): 15%
4. FIGS, Inc.: 12%
5. Owens & Minor: 10%
6. Henry Schein: 8%
7. Mölnlycke Health Care: 7%
8. Ansell Limited: 5%

FIGS, Inc. has established itself as a significant player in the medical apparel sector in recent years. FIGS' market share is approximately 12%, making them one of the leading companies in this segment. Their competitive advantage, or "moat," lies in their strong brand identity, innovative design, and direct customer engagement through digital channels.

Compared to larger competitors like Medline Industries and Cardinal Health, which have a broader product range and longer market presence, FIGS' moat is more specifically focused on their niche. While Medline and Cardinal Health benefit from their comprehensive product offerings and established distribution networks, FIGS has a significant advantage in direct customer engagement and brand loyalty through their specialized product line and focus on e-commerce.

However, FIGS' competitive advantage could be challenged by the expansion of larger companies into the specialized medical apparel sector. To strengthen their moat, FIGS would need to continue investing in innovation and customer retention.

Revenue Growth: 18% (2025) Gross Margin: 72% (2025) Net Income Growth: 15% (2025)

FIGS, Inc. recorded a revenue growth of 18% in 2025, attributed to strong demand for their specialized medical apparel products. The 72% gross margin indicates the company's ability to sell its products with a high profit margin, pointing to efficient production processes and a strong brand presence.

The 15% net income growth in 2025 suggests that FIGS was able to not only increase revenue but also manage costs well, leading to improved profitability. These metrics are a positive signal for potential investors as they indicate a healthy and growing business model.

Additionally, FIGS has invested in expanding its product offerings and entering new markets in recent years, which could support future growth. Given these factors, FIGS stock could present an attractive investment opportunity, especially for investors interested in a company with strong brand value and growth potential.

Dividend: None (As of 2023)

FIGS, Inc. has not paid any dividends so far. The company is known for reinvesting its profits into growth and expansion rather than distributing dividends to shareholders.

FIGS, Inc.'s strategy is focused on gaining market share and expanding its product lines. Therefore, it is unlikely that the company will introduce a dividend in the near future as long as the focus remains on growth.